1. Anukumar B, Sapkal GN, Tandale BV, Balasubramanian R, Gangale D. West nile encephalitis outbreak in Kerala, India, 2011. Journal of Clinical Virology. 2014;61(1):152–5.
2. Arankalle V, Virkar R, Tandale B, Ingle N. Utility of pandemic H1N1 2009 influenza virus recombinant hemagglutinin protein-based enzyme-linked immunosorbent assay for serosurveillance. Clinical and Vaccine Immunology. 2010;17(9):1481–3.
3. Balakrishnan A, Thekkekare RJ, Sapkal G, Tandale BV. Seroprevalence of Japanese encephalitis virus & West Nile virus in Alappuzha district, Kerala. The Indian journal of medical research. 2017;146(Suppl 1):S70.
4. Balakrishnana A, Thekkekara R, Tandale B. Outcomes of West Nile encephalitis patients after 1 year of West Nile encephalitis outbreak in Kerala, India: A follow-up study. Journal of Medical Virology. 2016;188(11):1856–61.
5. Dandona L, Dandona R, Kumar GA, Shukla D, Paul VK, Balakrishnan K, et al. Nations within a nation: variations in epidemiological transition across the states of India, 1990–2016 in the Global Burden of Disease Study. The Lancet. 2017;390(10111):2437–60.
6. Dandona R, Kumar GA, Henry NJ, Joshua V, Ramji S, Gupta SS, et al. Subnational mapping of under-5 and neonatal mortality trends in India: The Global Burden of Disease Study 2000–17. The Lancet. 2020;395(10237):1640–58.
7. Deoshatwar AR, Bondre VP, Tandale BV. Chickenpox and measles clusters among college students in Pune, Maharashtra. Virusdisease. 2017;28(3):337–40.
8. Gurav Y, Chadha M, Tandale B, Potdar V, Pawar S, Shil P, et al. Influenza A (H1N1) pdm09 outbreak detected in inter-seasonal months during the surveillance of influenza-like illness in Pune, India, 2012–2015. Epidemiology & Infection. 2017;145(9):1898–909.
9. Gurav YK, Bondre VP, Tandale BV, Damle RG, Mallick S, Ghosh US, et al. A large outbreak of Japanese encephalitis predominantly among adults in northern region of West Bengal, India. Journal of medical virology. 2016;88(11):2004–11.
10. Gurav YK, Raut CG, Yadav PD, Tandale BV, Sivaram A, Pore MD, et al. Buffalopox outbreak in humans and animals in Western Maharashtra, India. Preventive veterinary medicine. 2011;100(3):242–7.
11. Gurav YK, Tandale BV, Jadi RS, Gunjikar RS, Tikute SS, Jamgaonkar AV, et al. Chandipura virus encephalitis outbreak among children in Nagpur division, Maharashtra, 2007. 2010;
12. Gurav Y, Yadav P, Deoshatwar A, V D, Shete A, G C, et al. Serosurvey of Crimean Congo Hemorrhagic Fever (CCHF) among high risk group during 2011 and 2013 CCHF outbreak in India. Indian Journal of Applied Research. 2014;4(12):430–4.
13. Joshi M, Tandale B, Gore M, Bhalla S, Gurav Y, Sapkal G, et al. Evidence of hepatitis A virus infection in the patients with acute encephalitis syndrome in Gorakhpur region, North India. Acta virologica. 2018;62(2):208–13.
14. Kamaraj P, Khan S, Allam R, Barde P, Dwibedi B, Kanungo S, et al. Seroprevalence of Dengue Infection Using IgG Capture ELISA in India, 2017-2018. The American journal of tropical medicine and hygiene. 2021;
15. Kode SS, Pawar SD, Tandale BV, Parkhi SS, Barde TD, Mishra AC. Low level of cross-reactive antibodies to pandemic influenza (H1N1) 2009 virus in humans in pre-pandemic period in Maharashtra, India. Indian Journal of Virology. 2012;23(1):36–8.
16. Kongre VA, Pol SS, Bharadwaj RS, Gurav YK, Chadha MS, Tandale BV, et al. Bacteriological Study Among Influenza-like Illness Cases in a Community Setting in Pune, India. Cureus. 2018;10(11).
17. Kumar MS, Kamaraj P, Khan SA, Allam RR, Barde PV, Dwibedi B, et al. Seroprevalence of chikungunya virus infection in India, 2017: a cross-sectional population-based serosurvey. The Lancet Microbe. 2021;2(1):e41–7.
18. Kumar S, Jadi RS, Anakkathil SB, Tandale BV, Mishra AC, Arankalle VA. Development and evaluation of a real-time one step Reverse-Transcriptase PCR for quantitation of Chandipura Virus. BMC infectious diseases. 2008;8(1):168.
19. Murhekar MV, Kamaraj P, Kumar MS, Khan SA, Allam RR, Barde P, et al. Burden of dengue infection in India, 2017: a cross-sectional population based serosurvey. The Lancet Global Health. 2019;7(8):e1065–73.
20. Murhekar MV, Kamaraj P, Kumar MS, Khan SA, Allam RR, Barde PV, et al. Immunity against diphtheria among children aged 5–17 years in India, 2017–18: a cross-sectional, population-based serosurvey. The Lancet Infectious Diseases. 2021;21(6):868–75.
21. Murhekar MV, Kasabi GS, Mehendale SM, Mourya DT, Yadav PD, Tandale BV. On the transmission pattern of Kyasanur Forest disease (KFD) in India. Infectious diseases of poverty. 2015;4(1):1–4.
22. Murhekar MV, Kumar MS, Kamaraj P, Khan SA, Allam RR, Barde P, et al. Hepatitis-B virus infection in India: Findings from a nationally representative serosurvey, 2017-18. International Journal of Infectious Diseases. 2020;100:455–60.
23. Pawar SD, Tandale BV, Gurav YK, Parkhi SS, Kode SS. Immunity status against influenza A subtype H7N9 and other avian influenza viruses in a high-risk group and the general population in India. The Journal of infectious diseases. 2014;210(1):160–1.
24. Pawar SD, Tandale BV, Mali RS, Potdar VA, Kode SS, Biswas D, et al. Avian influenza A H7N9 virus infections not evident among high-risk groups in India. The Indian journal of medical research. 2016;144(6):942.
25. Pawar SD, Tandale BV, Raut CG, Parkhi SS, Barde TD, Gurav YK, et al. Avian influenza H9N2 seroprevalence among poultry workers in Pune, India, 2010. PLoS One. 2012;7(5):e36374.
26. Pawar SD, Tandale BV, Tare DS, Keng SS, Kode SS, Abraham P. Classical and molecular virology in the context of sars-cov-2. Journal of the Indian Medical Association. 2021;24–30.
27. Research IC of M, India PHF of, Evaluation IHM and. India: Health of the Nation’s States. Report. 2017;(1):0.
28. Sangole S, Tandale B, Bagde P, Thorat D. Evaluation of impact of health education regarding HIV/AIDS on knowledge and attitude among persons living with HIV. Indian Journal of Community Medicine. 2003;28(1):31–3.
29. Sharma S, Sen S, Anand K, Tandale B, Sinha N, Das N, et al. An Outbreak of JE/AES in North Bengal Districts of West Bengal during. J Commun Dis. 2014;46(2):51–8.
30. Shil P, Atre NM, Patil AA, Tandale BV, Abraham P. District-wise estimation of Basic reproduction number (R0) for COVID-19 in India in the initial phase. Spatial Information Research. 2021;1–9.
31. Tandale B, Chowdhury P, Rajderkar S, Shrivastava N. Epidemiology of Dengue. In: Monograph : Dengue. Jaypee Brothers Medical Publishers (P) Ltd. (India); 2019. p. 5–19.
32. Tandale B, Rajderkar S, Shrivastava N. Epidemiology of Dengue in India. In: Dengue in India. Association of Physicians of India; 2016. p. 19–31.
33. Tandale BV, Balakrishnan A, Yadav PD, Marja N, Mourya DT. New focus of Kyasanur Forest disease virus activity in a tribal area in Kerala, India, 2014. Infectious diseases of poverty. 2015;4(1):1–4.
34. Tandale BV, Bondre VP, Sapkal GN, Gopalkrishna V, GuravMD YK, Rao RK, et al. Childhood encephalitis hospitalizations associated with virus agents in medium-endemic states in India. Journal of Clinical Virology. 2021;104970.
35. Tandale BV, Khan SA, Kushwaha KP, Rahman H, Gore MM, Sapkal GN, et al. Effectiveness of Japanese encephalitis SA 14-14-2 live attenuated vaccine among Indian children: Retrospective 1: 4 matched case-control study. Journal of infection and public health. 2018;11(5):713–9.
36. Tandale BV, Pawar SD, Gurav YK, Chadha MS, Koratkar SS, Shelke VN, et al. Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in. 2009;
37. Tandale BV, Pawar SD, Gurav YK, Chadha MS, Koratkar SS, Shelke VN, et al. Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India. BMC infectious diseases. 2010;10(1):255.
38. Tandale BV, Pawar SD, Gurav YK, Parkhi SS, Mishra AC. Antibody persistence after Pandemic H1N1 2009 influenza vaccination among healthcare workers in Pune, India. Human vaccines & immunotherapeutics. 2013;9(1):125–7.
39. Tandale BV, Pawar SD, Mishra AC. Immunogenicity and safety of pandemic H1N1 2009 vaccine among adults in field use, India. Vaccine. 2011;30(12):2043–4.
40. Tandale BV, Sathe PS, Arankalle VA, Wadia R, Kulkarni R, Shah SV, et al. Systemic involvements and fatalities during Chikungunya epidemic in India, 2006. Journal of Clinical Virology. 2009;46(2):145–9.
41. Tandale BV, Tikute SS, Arankalle VA, Sathe PS, Joshi MV, Ranadive SN, et al. Chandipura virus: a major cause of acute encephalitis in children in North Telangana, Andhra Pradesh, India. Journal of medical virology. 2008;80(1):118–24.
42. Tandale B, YK G. Outbreak response and epidemiological research. In: National Institute of Virology - Golden to Diamond Jubilee: The glorious decade. Arankalle VA and Cecilia D; 2012. p. 1–12.
43. Tripathy AS, Tandale BV, Balaji SS, Hundekar SL, Ramdasi AY, Arankalle VA. Envelope specific T cell responses & cytokine profiles in chikungunya patients hospitalized with different clinical presentations. The Indian journal of medical research. 2015;141(2):205.
44. Van Kerkhove MD, Hirve S, Koukounari A, Mounts AW, H1N1pdm Serology Working Group. Estimating age‐specific cumulative incidence for the 2009 influenza pandemic: a meta‐analysis of A (H 1 N 1) pdm09 serological studies from 19 countries. Influenza and other respiratory viruses. 2013;7(5):872–86.
45. Viswanathan R, Tandale BV, Tamayachekar MS, Jadhav SM, Khutwad KA, Munne KR. Seroepidemiology of parvovirus B19 among different age groups & pregnant women in India. The Indian journal of medical research. 2017;146(1):138.
46. Yadav P, Deoshatwar A, Shete A, Tandale B, Patil D, Dalal S, et al. Serosurvey of Malsoor virus among Rousettus leschenaulti bat & human population residing nearby Robber’s cave, Mahabaleshwar, Maharashtra, India. The Indian journal of medical research. 2017;146(4):545.
47. Yergolkar PN, Tandale BV, Arankalle VA, Sathe PS, AB S, Gandhe SS, et al. Chikungunya outbreaks caused by African genotype, India. Emerging infectious diseases. 2006;12(10):1580.
